Tetrahydrofuran
- (48)
- (24)
- (5)
- (1)
- (3)
- (6)
- (1)
- (1)
- (22)
- (29)
- (2)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (17)
- (2)
- (6)
- (1)
- (5)
- (3)
- (1)
- (2)
- (58)
- (11)
- (1)
- (7)
- (8)
- (2)
- (3)
- (35)
- (8)
- (2)
- (8)
- (2)
- (41)
- (1)
- (2)
- (1)
- (4)
- (19)
- (23)
- (4)
- (1)
- (7)
- (4)
- (2)
- (6)
- (8)
- (12)
- (1)
- (8)
- (12)
- (3)
- (1)
- (1)
- (1)
- (4)
- (1)
- (5)
- (2)
- (2)
- (2)
- (3)
- (3)
- (7)
- (1)
- (1)
- (1)
- (2)
- (1)
- (2)
- (2)
- (1)
- (1)
- (9)
- (5)
- (2)
- (1)
- (2)
- (5)
- (1)
- (4)
- (3)
- (3)
- (5)
- (3)
- (1)
- (2)
- (2)
- (2)
- (3)
- (4)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (1)
- (4)
- (2)
- (1)
- (2)
- (2)
- (2)
- (1)
- (5)
- (2)
- (1)
- (1)
- (1)
- (4)
- (1)
- (1)
- (160)
- (6)
- (16)
- (11)
- (6)
- (8)
- (1)
- (5)
- (1)
- (2)
- (2)
- (2)
- (1)
- (3)
- (4)
- (9)
- (3)
- (2)
- (13)
- (3)
- (2)
- (11)
- (43)
- (18)
- (1)
- (2)
- (1)
- (3)
- (8)
- (1)
- (9)
- (1)
- (1)
- (6)
- (4)
- (26)
- (2)
- (2)
- (10)
- (7)
- (11)
- (4)
- (16)
- (37)
- (4)
- (22)
- (15)
- (6)
- (4)
- (4)
- (4)
- (5)
- (7)
- (5)
- (24)
- (5)
- (2)
- (1)
- (1)
- (2)
- (2)
- (7)
- (1)
- (3)
- (16)
- (6)
- (7)
- (25)
- (4)
- (2)
- (3)
- (3)
- (5)
- (9)
- (9)
- (1)
- (1)
- (7)
- (4)
- (3)
Filtered Search Results
Medchemexpress LLC BMS-1001 hydrochloride | 2113650-04-5 | 98.0% | 25 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
A small-molecule hydrochloride salt developed as an orally active inhibitor of the PD-1/PD-L1 immune checkpoint. Intended for preclinical research applications, it is supplied at research-grade purity with batch-specific documentation.
- Orally active PD-1/PD-L1 inhibitor for immunology research.
- Hydrochloride salt form to improve solubility.
- High purity suitable for preclinical studies (≈98.0%).
- Available in small-scale quantities for screening and assays.
- Supplied with certificate of analysis and batch data.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Ralaniten triacetate | 1637573-04-6 | 98.8% | 521.00 | C27H33ClO8 | 25MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Ralaniten triacetate is an orally active androgen receptor (AR) N-terminal domain (NTD) inhibitor used for preclinical research. It functions as a pro-agent of ralaniten, inhibiting AR transcriptional activity and showing activity against full-length and resistance-related AR species, including AR-v7. Consult the supplier documentation for handling, storage, purity, and safety information.
- First-in-class AR N-terminal domain inhibition.
- Active against full-length and resistant AR species such as AR-v7.
- Inhibits AR transcriptional activity.
- Suitable for research into castration-resistant prostate cancer models.
- Supplied with certificate of analysis and safety data sheet for quality verification.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC DS08210767 | 2376334-75-5 | 99.4% | 513.67 | C31H39N5O2 | 25MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
DS08210767 is a small-molecule antagonist of the parathyroid hormone receptor 1 (PTHR1) for research use. It is reported to be orally bioavailable and shows an in vitro IC50 of 90 nM against PTHR1. The compound is supplied as a light yellow to yellow solid with high reported purity and is intended for biochemical and cellular studies; follow manufacturer storage recommendations.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Dalpiciclib 50mg | 1637781-04-4 | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Dalpiciclib is an orally active, selective inhibitor of cyclin-dependent kinases CDK4 and CDK6 intended for preclinical research use. It is supplied as a powder and is characterized by CAS 1637781-04-4, molecular formula C25H30N6O2, and molecular weight 446.54 g/mol. For research use only; not for human or clinical use.
- Selective CDK4/6 inhibition with low-nanomolar potency
- High chemical purity suitable for analytical and biological studies
- Supplied as a powder for flexible formulation and dosing
- Stable under recommended storage conditions for long-term use
- Characterized by validated analytical data and CAS identification
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Rsm-932a | 850807-63-5 | 98.4% | 877.53 g/mol | C46H38Br2Cl2N4 | 10 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
RSM-932A is a small-molecule choline kinase α (ChoKα) inhibitor used in oncology research. It has demonstrated in vitro antiproliferative activity across multiple tumor-derived cell lines and shown antitumor effects in preclinical models. Supplied as a purified research compound for laboratory use only (not for human or veterinary use).
- Potent choline kinase α inhibitor with demonstrated antiproliferative activity.
- Effective in both in vitro and in vivo preclinical studies.
- High purity suitable for biochemical and cellular assays.
- Molecular weight 877.53 g/mol supports mass-based dosing and analysis.
- Available in small lab-scale quantities for experimental workflows.
- Intended for research use only; not for human or veterinary applications.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Melanin probe-2 | 1285446-04-9 | 99.4% | 300.19 | 100 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Melanin probe-2 (compound 5) is a non-radioactive bromopicolinamide precursor utilized in the synthesis of 18F-Labeled Picolinamide PET probes. This product is for research use only.
- Non-radioactive bromopicolinamide precursor
- Used for the synthesis of 18F-Labeled Picolinamide PET probe
- Research use only
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Vebicorvir (ABI-H0731) | 2090064-66-5 | 99.7% | 467.44 g·mol^-1 | C19H12F3N3O4S2 | 5 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Vebicorvir (ABI-H0731) is a research-grade small-molecule inhibitor of the hepatitis B virus (HBV) core protein. It functions as a core protein allosteric modulator that suppresses formation of covalently closed circular DNA (cccDNA) in cellular infection models. For research use only.
- Inhibits HBV core protein via allosteric modulation.
- Suppresses cccDNA formation in cellular models (reported EC50 1.84-7.3 μM).
- High chemical purity suitable for biochemical and cellular assays.
- Molecular formula C19H12F3N3O4S2; molecular weight 467.44 g·mol^-1.
- Supplied as a solid, soluble in common organic solvents.
- For research use only; not for human or clinical use.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Selnoflast | 2260969-36-4 | MFCD34579587 | 99.5% | 391.53 g/mol | C20H29N3O3S | 5 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Selnoflast is an orally active, selective, and reversible small-molecule inhibitor of the NLRP3 inflammasome, developed for research into inflammatory pathways and disease models. It is supplied for research use and is characterized by analytical data to support reproducible experimental use.
- Selective inhibitor of the NLRP3 inflammasome.
- Orally active and reversible small-molecule mechanism.
- Suitable for in vitro and in vivo inflammatory disease research.
- High purity supporting analytical consistency.
- Soluble in DMSO for standard assay formulations.
- Molecular weight 391.53 g/mol; molecular formula C20H29N3O3S.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Naz2329 | 2809469-05-2 | 99.0% | 501.56 g·mol⁻¹ | C21H18F3NO4S3 | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
NAZ2329 is a small-molecule research inhibitor that allosterically and preferentially inhibits receptor-type protein tyrosine phosphatases PTPRZ and PTPRG. It is supplied as a solid for laboratory research and is characterized by high purity and established solubility in DMSO.
- Allosterically inhibits PTPRZ and PTPRG (reported IC50: PTPRZ 7.5 μM, PTPRG 4.8 μM).
- Cas number 2809469-05-2.
- Purity 99.02%.
- Molecular formula C21H18F3NO4S3.
- Molecular weight 501.56 g·mol⁻¹.
- Appearance solid, white to off-white.
- Soluble in DMSO (~100 mg/mL).
- Pack size 50 mg.
- Storage: powder -20°C (up to 3 years) or 4°C (up to 2 years).
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC R - mg-132 100 mg
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
R -MG-132 100MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC MLS000544460 50 mg
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
MLS000544460 50MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC BEVUROGANT 100 mg
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
BEVUROGANT 100MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Morphiceptin | 74135-04-9 | 99.1% | 521.61 | 10 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Morphiceptin is a potent and specific agonist for morphine (μ) receptors. It is a synthetic peptide, an amide of a fragment of the milk protein β-casein. Morphiceptin exhibits morphinelike activities and shows high specificity for morphine (μ) receptors, but not for Enkephalin receptors. It potently inhibits the binding of [3H]dihydromorphine, 125I-labeled FK33824, and [3H]naloxone to rat brain membrane preparations with an IC50 of about 20 nM.
- Potent and specific agonist for morphine (μ) receptors
- Synthetic peptide derived from β-casein
- Exhibits morphinelike activities
- High specificity for morphine (μ) receptors over Enkephalin receptors
- Inhibits binding of [3H]dihydromorphine, 125I-labeled FK33824, and [3H]naloxone to rat brain membrane preparations
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Erk1/2 inhibitor 2 (ASTX-029) | 2095719-92-7 | >98.0% | 584.04 g/mol | C29H31ClFN5O5 | 25MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
ASTX029 is a dual-mechanism extracellular signal-regulated kinase (ERK) 1/2 inhibitor developed as a clinical candidate. It inhibits ERK catalytic activity and ERK phosphorylation, with reported ERK2 IC50 ≈ 2.7 nM, and has demonstrated antineoplastic activity in preclinical models and early clinical evaluation. Supplied as a crystalline solid for research use, typical vendor-reported purity is ≥98% (CAS 2095719-92-7).
- Potent dual-mechanism ERK inhibitor with low-nanomolar potency.
- Inhibits both catalytic activity and phosphorylation of ERK.
- Demonstrated antineoplastic activity in preclinical and early clinical studies.
- Supplied as a crystalline solid suitable for in vitro and in vivo formulation.
- Typical purity ≥98% by vendor testing.
- CAS number 2095719-92-7 and molecular weight ≈584.04 g/mol.
- For research use only; not for human therapeutic use.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC DS08210767 | 2376334-75-5 | 99.4% | 513.67 g/mol | C31H39N5O2 | 100MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
DS08210767 is a small-molecule antagonist of parathyroid hormone receptor 1 (PTHR1), described as highly potent and orally bioavailable with an IC50 of 90 nM. It is provided as a research-grade, well-characterized compound suitable for receptor pharmacology and oral in vivo studies.
- High potency (IC50 of 90 nM) for PTHR1 inhibition.
- Orally bioavailable, enabling oral dosing in pharmacology studies.
- High purity (99.4%) as verified by certificate of analysis.
- Molecular weight 513.67 g/mol; formula C31H39N5O2.
- Analytical data available: COA, HNMR, and LCMS.
- Supplied in multiple milligram pack sizes for experimental flexibility.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More